1. Both short-and long-term treatment with the direct AMP kinase activator PXL770 improves cardiac function in ZSF-1 rats. (14th October 2021) Authors: Stephan, Y; Souille, M; Larcheveque, M; Gluais-Dagorn, P; Hallakou-Bozec, S; Nicol, L; Mulder, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗